Health Trials

Tumor Recurrence

2

Review clinical trials related to Tumor Recurrence. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.

A phase 1, multicenter, open label, non-randomized dose escalation and dose expansion study to examine the maximum tolerated dose, (MTD), minimum effective dose (MED) and/or recommended dose for expansion (RDE) of intratumoral ONM-501 as monotherapy and in combination with a PD-1 checkpoint inhibitor in patients with advanced solid tumors and lymphomas.

Participants needed: 168
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: OncoNano Medicine, Inc.Updated: Dec 24, 2025Locations: 16
Eligibility criteria

Ability to understand and willingness to sign written informed consent before pe... [+6]

Other malignancy active within the previous 2 years except for basal or squamous... [+12]

Read more
Status: Recruiting

Clinical Study on the Re-irradiation of Lateral Pelvic Recurrences of Gynecological Malignancies

The study aims to obtain a local control rate in patients with lateral pelvic relapses of gynecologycal cancers previously irradiated. High LET (Linear Energy Transfer) particles as carbon ions can guarantee a biologic advantage compared to photons in radioresistant neoplasms, given to their higher biological efficacy (RBE).

Participants needed: 55
Trial details
Age: 18+Biological sex: FemaleType: InterventionalSponsor: CNAO National Center of Oncological HadrontherapyUpdated: Aug 6, 2025Locations: 1
Eligibility criteria

Patients ≥ 18 years of age [+11]

Hip prosthesis, metal prostheses or any other condition that prevents adequate i... [+9]

Read more